Sarah Pringle
Webster's CenExel readies sale and MSCP joins booming HVAC mark.
The clinical site organization's concentrated model offering centralized capabilities is considered compelling to pharma companies and CROs looking to depend on fewer outsourced providers.
ArchiMed acquired natural ingredients company Fytexia in 2016 through its MED I fund, which raised €150 million in 2015.
The tech company names new members to its board of directors to lead the vision for its next phase of growth.
At $16 a share, the transaction implies a 24% premium to Cloudera's closing share price on May 28, and 30% premium to the 30-day volume weighted average share price.
Representing one of the first platforms to grow and consolidate the oral surgery market, RiverGlade and Thurston formed USOSM in late 2017.
The assessment of Corialis’ ESG performance will be monitored and externally verified by a third-party sustainability rating and associated annual targets over the life of the financing.
Atlas invested in Banker Steel in 2014 and has since executed seven add-on acquisitions.
MidOcean generates handsome return on The Planet Group, Riverside exits Greenphire for ~$1.1b as Thoma bets on future of clinical research
MidOcean generated an 88% IRR on the sale of the human capital platform to ProPharma Group, a portfolio company of Odyssey Investment Partners.